Provided By GlobeNewswire
Last update: Mar 27, 2025
– Presented preclinical non-human primate (NHP) data at the 20th Congress of European Crohn’s and Colitis Organization in Inflammatory Bowel Diseases 2025 (ECCO) for SL-325, a potentially first-in-class blocking antibody to DR3, the receptor for TL1A; data demonstrated favorable safety profile, full receptor occupancy, lack of DR3 agonism –
Read more at globenewswire.com0.7733
+0.02 (+2.41%)
Find more stocks in the Stock Screener
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
As we await the opening of the US market on Tuesday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.
The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.
Here are the top movers in Monday's session, showcasing the stocks with significant price changes.